Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adai Technology is an AI-driven biotechnology company headquartered in Beijing, China, that specializes in accelerating drug discovery through advanced computational intelligence. The company utilizes its proprietary AI platform to integrate deep learning, structural biology, and medicinal chemistry for the design and optimization of novel small molecule therapeutics. Adai Technology focuses on addressing high-value targets in therapeutic areas such as oncology and immunology, aiming to improve the efficiency and success rates of the drug development process. By leveraging high-performance computing and massive biological datasets, the firm provides innovative solutions for lead identification and ADMET prediction. Adai Technology operates both through internal drug discovery programs and strategic collaborations with pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adai Technology.